Dynamics of the immune repertoire in recurrent, locally advanced NSCLC not amenable for definitive therapy and in stage IV disease receiving first-line chemotherapy.

Front Oncol · 2026 · PMC13111021 · PMID 42052466

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Changing of immune repertoire and clinical correlation in pre and post chemotherapy period (Time Points 1 and 2) Shannon diversity was slightly higher and more variable in the PD group (5.91) compared with the disease control group (5.84), although the difference did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.